Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Multivariate analysis of determinants of short-term MACE

From: Comparison of in-hospital glycemic variability and admission blood glucose in predicting short-term outcomes in non-diabetes patients with ST elevation myocardial infarction underwent percutaneous coronary intervention

Independent variables HR 95% CI p value
Lower Upper
Age (per decade) 2.158 1.435 3.245 <0.001
LVEF <40% 3.137 1.543 6.380 0.002
TIMI flow after PCI < grade 3 2.984 1.276 6.980 0.012
MAGE >3.26 mmol/L 2.271 1.154 4.471 0.018
  1. MACE major adverse cardiac events, HR hazard ratio, CI confidence interval, LVEF left ventricular ejection fraction, TIMI thrombolysis in myocardial infarction, PCI percutaneous coronary intervention, MAGE the mean amplitude of glycemic excursions